A Common Polymorphism of the Protein Z Gene Is Associated With Protein Z Plasma Levels and With Risk of Cerebral Ischemia in the Young
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (1) , 40-45
Abstract
Background and Purpose— The vitamin K–dependent protein Z (PZ) has been shown to possess anticoagulant as well as procoagulant properties. Plasma levels of PZ show a broad interindividual variation, but it is unknown to which extent this variation is under genetic control. Recent clinical studies revealed contradictory results on the association of PZ plasma levels and the risk of ischemic stroke. Methods— We performed a case-control study including 200 patients with cerebral ischemia aged ≤50 years and 199 control subjects from the same South German region. We investigated a possible association of 2 common single nucleotide mutations in the PZ gene with the risk of cerebral ischemia. Furthermore, enzyme-linked immunosorbent assay measurements were done in control subjects without vascular disease to detect a potential association of different genotypes with PZ plasma (antigen) levels. Results— In patients, the frequency of the A allele of the intron F polymorphism G79A was significantly lower than in controls (15.7% versus 24.4%; odds ratio, 0.58; 95% CI, 0.39 to 0.86; P =0.007; adjusted for age, sex, and conventional risk factors). The G allele of the promoter polymorphism A-13G tended to be less common in patients (4.2% versus 7.0%; adjusted odds ratio, 0.56; 95% CI, 0.28 to 1.13; P =0.105). In 42 control subjects, the A allele of the intron F polymorphism was associated with lower PZ antigen levels ( P =0.0032; Spearman correlation coefficient r s =−0.48). Conclusions— The A allele of an intron F polymorphism of the PZ gene appears to be a novel protective genetic marker for the risk of cerebral ischemia in young adults. In the context of juvenile stroke, high PZ plasma levels may represent a prothrombotic condition.Keywords
This publication has 22 references indexed in Scilit:
- Prothrombin G20210A Mutation, but Not Factor V Leiden, Is a Risk Factor in Patients with Persistent Foramen ovale and Otherwise Unexplained Cerebral IschemiaCerebrovascular Diseases, 2003
- Low Protein Z Levels and Risk of Ischemic Stroke: Differences by Diabetic Status and GenderBlood Cells, Molecules, and Diseases, 2002
- Protein ZSeminars in Thrombosis and Hemostasis, 2001
- Protein-Z and thrombosisThe Lancet, 2001
- Frequency of protein Z deficiency in patients with ischaemic strokeThe Lancet, 2001
- Analytical Evaluation of Primer Engineered Multiplex Polymerase Chain Reaction–Restriction Fragment Length Polymorphism for Detection of Factor V Leiden and Prothrombin G20210AThe Journal of Molecular Diagnostics, 2000
- The Gene for Human Protein Z Is Localized to Chromosome 13 at Band q34 and Is Coded by Eight Regular Exons and One Alternative Exon,Biochemistry, 1998
- Traditional Risk Factors and Ischemic Stroke in Young Adults: The Baltimore-Washington Cooperative Young Stroke StudyArchives of Neurology, 1996
- Protein Z deficiency: A new cause of bleeding tendencyThrombosis Research, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993